Market Overview

UPDATE: Piper Jaffray Reduces PT to $67 on Albemarle on Bromine Derivatives Visibility

Related ALB
Top 4 Mid-Cap Stocks In The Specialty Chemicals Industry With The Highest ROI
Earnings Scheduled For October 22, 2014

Piper Jaffray reiterated its Overweight rating on Albemarle (NYSE: ALB) and lowered its price target from $72 to $67.

Piper Jaffray commented, "At this point, Albemarle is largely a 2013 story, with Fine Chemistry doubling capacity to keep pace and NBPT exhibiting robust growth, and Catalysts expecting a solid lead-in to 2013 on higher HPC volumes y/y. The larger question marks are olumes and pricing for bromine derivatives, for which we expect more clarity post Chinese New Year."

Albemarle closed at $55.33 on Friday.

Latest Ratings for ALB

DateFirmActionFromTo
Dec 2014NomuraInitiates Coverage onBuy
Nov 2014JefferiesMaintainsBuy
Oct 2014Deutsche BankUpgradesHoldBuy

View More Analyst Ratings for ALB
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (ALB)

Around the Web, We're Loving...

Get Benzinga's Newsletters